Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;136(5):604-20.
doi: 10.1017/S0950268807009041. Epub 2007 Jul 5.

Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies

Affiliations

Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies

L Coudeville et al. Epidemiol Infect. 2008 May.

Abstract

A compartmental, age-structured mathematical model was developed and recent US pertussis epidemiology data were used to evaluate the impact on pertussis infection rates of routine and targeted adult immunization strategies. Model simulations predict that the implementation of adolescent immunization only could reverse the current rise in pertussis infection rates but may lead to a resurgence of pertussis in subsequent decades. In contrast, inclusion of a routine adult strategy is likely to lead to sustained control of pertussis. Routine adult vaccination could control the disease even with relatively low coverage rates of 40% for routine vaccination of all adults every 10 years, or 65% for a targeted vaccination of close contacts of newborns completed by one booster dose for all adults. The model also predicts that the optimal age for this booster dose is 40 years. These results support the 2006 American Academy of Immunization Practices' recommendations for adolescent and adult vaccination against pertussis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Diagram of the immunological and infectious states and transitions between states in the age-specific pertussis model. WN1–3, Waning of natural immunity 1–3; V1–V4, vaccination status 1–4; WV1–3, waning vaccine 1–3; vc, vaccine coverage.
Fig. 2
Fig. 2
(a) Annual, age-specific incidence of pertussis (■, typical cases; □, mild cases) derived from the model for the current vaccination schedule (base case). (b) Comparison of the age-specific force of infection in absence of vaccination used in Van Rie & Hethcote [8] and derived from US data in this analysis.
Fig. 3
Fig. 3
Evolution over time of the annual incidence of symptomatic pertussis. vc, Vaccination coverage.
Fig. 4
Fig. 4
Annual, age-specific incidence of symptomatic (typical+mild) pertussis cases once steady state situation has been reached. vc, Vaccination coverage.
Fig. 5
Fig. 5
Impact of the age of adult booster dose of pertussis vaccine on the annual pertussis incidence and on the annual number of vaccinations needed.
Fig. 6
Fig. 6
Impact of vaccination coverage rate on annual pertussis incidence and annual number of vaccinations by adult vaccination strategy. (a) Childhood+adolescent+cocoon strategy. (b) Childhood+adolescent+routine adult every 10 years.

Similar articles

Cited by

References

    1. Cherry JD. The science and fiction of the ‘resurgence’ of pertussis. Pediatrics. 2003;112:405–406. - PubMed
    1. Anon. Pertussis – United States, 1997–2000. Morbidity and Mortality Weekly Reports. 2002;51:73–76. - PubMed
    1. Broder KR et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Reports. Recommendations and Reports. 2006;55(RR03):1–34. - PubMed
    1. Halperin SA et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine. 2000;18:1312–1319. - PubMed
    1. Ward JI et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. New England Journal of Medicine. 2005;353:1555–1563. - PubMed

Publication types

Substances